Does Medicare Cover Ozempic or Wegovy? What Metro Detroit Retirees Need to Know About the New GLP-1 Bridge
You've probably seen the headlines: "Medicare Now Covers Weight Loss Drugs." What you probably haven't seen is the fine print — because the fine print is where most of the confusion lives.
If you're a Metro Detroit retiree wondering whether your Ozempic prescription just got cheaper, or whether you even qualify for this new coverage, the honest answer is: it depends, and it's more specific than most of what's circulating online. Below is exactly what changed on July 1, 2026, who it actually helps, and what to do next.
What Is the Medicare GLP-1 Bridge?
On July 1, 2026, Medicare launched a temporary program called the GLP-1 Bridge. It's scheduled to run through December 31, 2027. This isn't a permanent change to Medicare Part D — it's a carve-out program that operates outside your normal Part D benefit, created specifically because federal law has long prohibited Part D from covering drugs prescribed purely for weight loss.
If you qualify, the Bridge covers a flat $50 copay for a 30-day supply of certain GLP-1 medications.
Which Drugs Are Actually Covered?
This is where most of the confusion starts. The Bridge program covers exactly three medications:
- Wegovy (injection or tablet form)
- Zepbound (KwikPen formulation only)
- Foundayo
Ozempic and standard Mounjaro are not included. Here's the part that trips up almost everyone: Ozempic and Wegovy are actually the same drug — semaglutide — made by the same manufacturer. The only difference is the brand name and what each is FDA-approved for. Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management. Mounjaro and Zepbound work the same way — both are tirzepatide, just approved for different uses.
So if your doctor prescribes Ozempic or Mounjaro for diabetes, that may already be covered through your regular Part D formulary — through a completely separate coverage path, with different rules and different costs. But it won't route through the Bridge, because those brands aren't approved for weight loss, even though the underlying drug is chemically identical to the ones that are.
Who Qualifies for the GLP-1 Bridge?
Eligibility runs across three BMI tiers, and this is the detail most sources get wrong or oversimplify:
- BMI of 35 or higher — qualifies automatically, no additional condition required.
- BMI of 30 to 34.9 — qualifies with a condition such as heart failure, uncontrolled high blood pressure, chronic kidney disease, prediabetes, a prior heart attack or stroke, or peripheral artery disease.
- BMI of 27 to 29.9 — qualifies with prediabetes, a prior heart attack or stroke, or peripheral artery disease.
On top of the BMI requirement, you must already be enrolled in a Medicare Part D plan — either a standalone prescription drug plan or a Medicare Advantage plan that includes drug coverage. Your doctor also has to submit a prior authorization confirming you meet the criteria before your pharmacy can process the $50 copay.
What Does It Cost — and How Long Will It Last?
If you're approved, you pay a flat $50 for a 30-day supply. That's a significant drop from retail prices, which can run anywhere from $500 to over $1,000 a month without coverage.
But the Bridge is a temporary demonstration program, currently scheduled to run through December 31, 2027. What happens after that hasn't been decided yet, so this isn't guaranteed to be a permanent benefit.
How to Find Out If You Qualify
Start with three steps:
- Confirm your Part D enrollment. You need a standalone prescription drug plan or a Medicare Advantage plan that includes drug coverage.
- Talk to your doctor. Ask whether your BMI or a qualifying health condition meets the criteria, and have them submit the prior authorization request.
- Check your enrollment window. If you don't currently have Part D, Medicare's Annual Enrollment Period runs October 15 through December 7 — that's your opportunity to enroll for coverage that could make you eligible next year.
FAQ: What Metro Detroit Retirees Are Asking
Does Medicare cover Ozempic for weight loss?
No. Ozempic is approved for type 2 diabetes, not weight loss, and it is not included in the Medicare GLP-1 Bridge program. If it's prescribed for diabetes, it may be covered through your regular Part D plan instead.
How much does Wegovy cost with Medicare in 2026?
If you qualify for the GLP-1 Bridge, the copay is a flat $50 for a 30-day supply. Without coverage, Wegovy can cost several hundred dollars a month or more.
Do I need a specific BMI to qualify?
Yes, and it depends on your tier. A BMI of 35 or higher qualifies on its own. A BMI of 30–34.9 needs an added condition like heart failure, high blood pressure, kidney disease, prediabetes, or a prior heart attack, stroke, or PAD. A BMI as low as 27–29.9 can still qualify, but only with prediabetes, a prior heart attack or stroke, or PAD.
Is the GLP-1 Bridge a permanent Medicare benefit?
No. It's a temporary program currently scheduled to run through December 31, 2027.
What if I don't have Medicare Part D yet?
You'll need to enroll in a Part D plan or a Medicare Advantage plan with drug coverage before you can use the Bridge. Medicare's Annual Enrollment Period runs October 15 through December 7.
Is Ozempic the same drug as Wegovy?
Yes — both contain semaglutide, made by the same manufacturer. The difference is the FDA-approved use and the brand name, not the medication itself.
Ready to Find Out Where You Stand?
If you're a Metro Detroit retiree trying to figure out whether this program actually applies to you — or whether your current Part D plan is even set up to take advantage of it — that's exactly the kind of detail I help clients sort through every day.
At Lifestyle Safety LLC, I offer a free Six-Pillar Retirement Review where we look at your Medicare coverage alongside your full retirement picture. Schedule yours at LifestyleSafety.com, or call (313) 450-9543. Serving Wayne, Oakland, and Macomb Counties.